Research Associate (609134)
 

Strathclyde Institute of Pharmacy and Biomedical Sciences seeks to appoint a Postdoctoral Research Assistant with experience in antibody engineering as part of a BBSRC Prosperity Partnership researching next-generation antibody-drug conjugates. You will work closely with GlaxoSmithKline and engage with the wider UK academic landscape.

Salary range: £36,024 (restricted due to funding) 

FTE: 1.0

Term: Fixed Term (12 months)

Closing date: 10 May 2024

 

Strathclyde Institute of Pharmacy and Biomedical Science seeks to appoint a Postdoctoral Research Assistant with experience in antibody engineering and analysis in an interdisciplinary team of chemists, biologists, and formulation scientists as part of a BBSRC Prosperity Partnership award researching the development of next-generation antibody-drug conjugates. You will possess a science-based education to PhD level (or significant relevant experience) with related degree in the Pharmaceutical Sciences, Biological Chemistry or equivalent relevant qualification. You will have considerable science-based technical experience to support a range of laboratory procedures including the bioproduction and conjugation of antibodies, cell culture and the use of analytical equipment to study conjugate biophysical properties. Working as a team member, you will be highly organised with a positive approach to working in a dynamic research environment. You will work closely with industry collaborators from GlaxoSmithKline and engage with the wider UK academic landscape and industrial partners.

 

This post is of 12 months duration in the first instance, and the post will be renewed for up to five years in total. 

 

Informal enquiries about the post can be directed to Dr Zahra Rattray, Senior Lecturer in Translational Pharmaceutics (zahra.rattray@strath.ac.uk).

 

It is anticipated that formal interviews for this post will be held in May 2024.

 

Click here for full details

 

 

 

Faculty
Faculty of Science
Department/School
Strathclyde Institute of Pharmacy and Biomedical Sciences
Staff Category
Research
Type of Employment
Fixed-term
Working Hours
Full-time
Vacancy Description
Strathclyde Institute of Pharmacy and Biomedical Sciences seeks to appoint a Postdoctoral Research Assistant with experience in antibody engineering as part of a BBSRC Prosperity Partnership researching next-generation antibody-drug conjugates. You will work closely with GlaxoSmithKline and engage with the wider UK academic landscape.
 

Salary range: £36,024 (restricted due to funding) 

FTE: 1.0

Term: Fixed Term (12 months)

Closing date: 10 May 2024

 

Strathclyde Institute of Pharmacy and Biomedical Science seeks to appoint a Postdoctoral Research Assistant with experience in antibody engineering and analysis in an interdisciplinary team of chemists, biologists, and formulation scientists as part of a BBSRC Prosperity Partnership award researching the development of next-generation antibody-drug conjugates. You will possess a science-based education to PhD level (or significant relevant experience) with related degree in the Pharmaceutical Sciences, Biological Chemistry or equivalent relevant qualification. You will have considerable science-based technical experience to support a range of laboratory procedures including the bioproduction and conjugation of antibodies, cell culture and the use of analytical equipment to study conjugate biophysical properties. Working as a team member, you will be highly organised with a positive approach to working in a dynamic research environment. You will work closely with industry collaborators from GlaxoSmithKline and engage with the wider UK academic landscape and industrial partners.

 

This post is of 12 months duration in the first instance, and the post will be renewed for up to five years in total. 

 

Informal enquiries about the post can be directed to Dr Zahra Rattray, Senior Lecturer in Translational Pharmaceutics (zahra.rattray@strath.ac.uk).

 

It is anticipated that formal interviews for this post will be held in May 2024.

 

Click here for full details